Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look.

Angela Dalia RicciAlessandro RizzoGiovanni Brandi

Published in: Cancer control : journal of the Moffitt Cancer Center (2021)

Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape of several malignancies, the role of immunotherapy in biliary tract cancer (BTC) is currently under investigation and ICIs are still looking for their niche in this setting. In this Editorial, we discuss recently published data regarding ICIs in BTC, with a particular focus in terms of selection of patients and biomarker-driven trials.

Keyphrases

papillary thyroid
end stage renal disease
squamous cell
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
lymph node metastasis
randomized controlled trial
squamous cell carcinoma
big data
young adults
deep learning